Last reviewed · How we verify
NCT03138174: OTVFSA
OneTouch Verio Flex System Accuracy Evaluation
trial testing OneTouch Verio Flex Blood Glucose Monitoring System in Diabetes Mellitus in 100 participants. Completed in 2 May 2017.
2 May 2017
Quick facts
| Lead sponsor | LifeScan |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 23 March 2017 |
| Primary completion | 2 May 2017 |
| Estimated completion | 2 May 2017 |
| Sites | 3 locations across United Kingdom |
Drugs / interventions tested
- OneTouch Verio Flex Blood Glucose Monitoring System
Conditions studied
- Diabetes Mellitus — all drugs for Diabetes Mellitus →
Sponsor
LifeScan
Who can join
12 and older, any sex, with Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Clinical System Accuracy Evaluation of the CE Marked One Touch Verio Flex blood glucose monitoring device as per requirements stated in ISO 15197:2015. To meet the requirements, glucose samples must be distributed over the operating range of the blood glucose monitor as stipulated in ISO:15197
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03138174
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetes Mellitus
Currently open trials in the same condition.
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07392437 — Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and I · NA · recruiting
- NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
- NCT07425275 — Integrated Oral Care Intervention for Xerostomia in Diabetes Patients · NA · recruiting
- NCT06918977 — Improving Glycemic Control With Telemedicine and Smart Insulin Pens · NA · recruiting
Other LifeScan trials
Trials by the same sponsor.
- NCT05354297 — Evidence for Health Improvement in People With Diabetes Using One Touch & Partner Solutions · NA · unknown
- NCT03556605 — Tu Salud (Your Health) Randomized Control Study in Patients With Diabetes Using a Mobile App. · NA · unknown
- NCT02929654 — Assessment of Blood Glucose Monitoring Devices With New Insight Features · NA · completed
- NCT03189225 — Capillary And Venous Accuracy: LifeScan Products vs Hospital Reference and YSI · NA · completed
- NCT02374879 — User Performance and System Accuracy Evaluations Using Glucose Adjustment · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03138174 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by LifeScan
- Last refreshed: 28 June 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03138174.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing